Hypertrichosis-acromegaloid facial appearance syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:966
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hypertrichosis-acromegaloid facial appearance syndrome (also known as acromegaloid facial appearance syndrome or AFA syndrome) is an extremely rare genetic condition characterized by the combination of excessive hair growth (hypertrichosis) and distinctive facial features that resemble those seen in acromegaly, but without the hormonal abnormalities associated with that condition. Growth hormone levels are normal in affected individuals. The key clinical features include a coarse, acromegaloid facial appearance with thickened lips, prominent jaw (prognathism), broad nose, thickened intraoral mucosa, and a large head. Generalized hypertrichosis (excessive body hair growth) is present from birth or early childhood. Additional features may include thickened skin, large hands and feet, and joint hypermobility. Importantly, affected individuals typically have normal intelligence and normal endocrine function, distinguishing this condition from true acromegaly caused by excess growth hormone. There is no specific cure or targeted treatment for this syndrome. Management is symptomatic and supportive, focusing on cosmetic concerns related to hypertrichosis (such as hair removal techniques) and monitoring for any associated complications. Genetic counseling is recommended for affected families. The condition appears to follow an autosomal dominant inheritance pattern, though sporadic cases have also been reported. Due to its extreme rarity, with only a small number of families and isolated cases described in the medical literature, the full clinical spectrum of the condition is not yet completely understood.

Also known as:

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Hypertrichosis-acromegaloid facial appearance syndrome.

View clinical trials →

No actively recruiting trials found for Hypertrichosis-acromegaloid facial appearance syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hypertrichosis-acromegaloid facial appearance syndrome community →

No specialists are currently listed for Hypertrichosis-acromegaloid facial appearance syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hypertrichosis-acromegaloid facial appearance syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hypertrichosis-acromegaloid facial appearance syndromeForum →

No community posts yet. Be the first to share your experience with Hypertrichosis-acromegaloid facial appearance syndrome.

Start the conversation →

Latest news about Hypertrichosis-acromegaloid facial appearance syndrome

No recent news articles for Hypertrichosis-acromegaloid facial appearance syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hypertrichosis-acromegaloid facial appearance syndrome

What is Hypertrichosis-acromegaloid facial appearance syndrome?

Hypertrichosis-acromegaloid facial appearance syndrome (also known as acromegaloid facial appearance syndrome or AFA syndrome) is an extremely rare genetic condition characterized by the combination of excessive hair growth (hypertrichosis) and distinctive facial features that resemble those seen in acromegaly, but without the hormonal abnormalities associated with that condition. Growth hormone levels are normal in affected individuals. The key clinical features include a coarse, acromegaloid facial appearance with thickened lips, prominent jaw (prognathism), broad nose, thickened intraoral

How is Hypertrichosis-acromegaloid facial appearance syndrome inherited?

Hypertrichosis-acromegaloid facial appearance syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hypertrichosis-acromegaloid facial appearance syndrome typically begin?

Typical onset of Hypertrichosis-acromegaloid facial appearance syndrome is neonatal. Age of onset can vary across affected individuals.